Concert for Cures with Elton John on Friday, May 9 at Petco Park. Tickets on sale now!
Please join us for an interactive panel discussion and talk-back as we explore the disparities that currently exist within areas of cancer research and care, and how Curebound is building a strategy to drive more equitable outcomes through our collaboration.
Our panel converges local experts from all facets of the cancer research continuum, ranging from immunology to population science to biotech commercialization of cancer drugs looking to integrate more diverse patient populations.
The CDC defines cancer equity as when the population has an equal opportunity to prevent cancer, find it early, and get proper treatment and follow-up after treatment is completed. We know that across the country and within San Diego, large disparities exist across the region resulting in certain populations having worse outcomes from cancer than others. The factors that drive these disparities are diverse and include area of residence, race, ethnicity, education, physical or mental abilities, and income. These differences in health among groups of people that are linked to social, economic, geographic, or environmental disadvantage are known as health disparities.
Upon launching in 2021, Curebound outlined five cancer research pillars to frame investments in cancer research across our six beneficiary institutions, including a commitment to fund research focused on addressing disparities in the community. Our discussion on April 18 will provide an opportunity to learn how the cancer research roadmap is progressing and a strategic discussion the complexities of cancer inequities and how our community can collaborate to drive equities in cancer care.